Universidade de São Paulo, Brazil.
Arq Bras Cardiol. 2010 Sep;95(3):373-80. doi: 10.1590/s0066-782x2010005000098. Epub 2010 Jul 30.
Currently there are several types of interventions for the treatment of heart failure (HF). Among these are beta-blocker therapy (BB) and physical training (PT). However, the effects of the combination of these therapies are poorly studied.
To investigate the effects of BB treatment with metoprolol (M) and carvedilol (C) associated with PT in mice with HF.
We used a genetic model of sympathetic hyperactivity-induced heart failure in mice. Initially, we divided the HF animals into three groups: sedentary (S); trained (T); treated with M (138 mg/kg) (M); or C (65 mg/kg) (C). In the second part, we divided the groups into three subgroups: sedentary (S); trained and treated with M (TM); and trained and treated with C (CT). The PT consisted of aerobic training on a treadmill for 8 weeks. Exercise tolerance was assessed by maximal graded test, and fractional shortening (FS) was assessed by echocardiography. Cardiomyocyte diameter and collagen volume fraction were evaluated by histological analysis. Data were compared by one way ANOVA and post hoc Duncan test. The significance level was set at p ≤ 0.05.
As to FS and cardiac remodeling, we found that, in isolation, T, M, and C showed an improvement of the variables analyzed. As to therapy combination, after the intervention period, we observed an increase in exercise tolerance in MT and CT (43.0% and 33.0% respectively). There was also a reduction in cardiomyocyte diameter (10.0% and 9.0% respectively) and in collagen volume fraction (52.0% and 63.0%) after the intervention. However, only CT significantly improved FS.
The association of PT with M or C therapies provided benefits on cardiac function and remodeling in HF mice.
目前有几种治疗心力衰竭(HF)的干预方法。其中包括β受体阻滞剂治疗(BB)和身体训练(PT)。然而,这些疗法联合应用的效果研究甚少。
研究β受体阻滞剂美托洛尔(M)和卡维地洛(C)联合 PT 对 HF 小鼠的治疗效果。
我们使用了一种由交感神经活性诱导的 HF 小鼠遗传模型。最初,我们将 HF 动物分为三组:久坐(S);训练(T);用 M(138mg/kg)(M)治疗;或 C(65mg/kg)(C)治疗。在第二部分,我们将各组分为三组:久坐(S);训练并用 M 治疗(TM);和训练并用 C 治疗(CT)。PT 包括在跑步机上进行 8 周的有氧运动训练。通过最大分级测试评估运动耐量,通过超声心动图评估分数缩短(FS)。通过组织学分析评估心肌细胞直径和胶原容积分数。数据通过单因素方差分析和事后 Duncan 检验进行比较。显著性水平设为 p≤0.05。
就 FS 和心脏重构而言,我们发现,单独的 T、M 和 C 均能改善分析变量。至于联合治疗,干预后,我们观察到 MT 和 CT 运动耐量增加(分别为 43.0%和 33.0%)。干预后心肌细胞直径(分别为 10.0%和 9.0%)和胶原容积分数(分别为 52.0%和 63.0%)也有所减少。然而,只有 CT 能显著改善 FS。
PT 联合 M 或 C 治疗对 HF 小鼠的心功能和重构有益。